Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medroxyprogesterone acetate versus Cetrotide for prevention of premature LH surge in IVF cycles
IRCT2017010813566N8Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jan 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2 trial of medroxyprogesterone acetate and cetrorelix in female infertility (2 arms), sponsored by Tabriz University of Medical Sciences. Started Jan 2017; status: completed.
02
Drugs
medroxyprogesterone acetatecetrorelix
03
Conditions
female infertility
Beyond the preview
Go deeper on IRCT2017010813566N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017010813566N8.